A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Primary outcomes

• Baseline characteristics of patients who have recurrent symptomatic genital herpetic disease [day of questionnaire]: To determine using a questionnaire * number of annual outbreaks of patients who have recurrent symptomatic genital herpetic disease * number of patients using suppressiv antiviral therapy * number of patients using antivirals for the treatment of outbreaks * number of patients using symptomatic therapy other than antivirals
• Acceptance to patients of clinical trial procedures [day of questionnaire]: To determine using a questionnaire \- the acceptance to patients of clinical trial procedures
• Interest in participation in genital herpes vaccine trials [day of questionnaire]: To determine using a questionnaire the number of patients interested in participation in genital herpes vaccine trials

Sex: All, ages: 18 Years to 64 Years

Inclusion Criteria:

* Able to understand and willing to sign the informed consent document.
* Patient confirmation of a diagnosis of HSV-2 infection at least 2 years prior to inclusion. Laboratory confirmation is not required.
* Symptomatic recurrent genital herpetic disease for >2 years supported by compatible clinical history

Exclusion Criteria:

* Subjects who do not meet the inclusion criteria for the study
* Subjects who are unable to provide legally effective informed consent

• Rajul Patel, Principal investigator, Solent NHS Trust